Trial
NCT06549296
Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune Diseases
Early Phase ISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Nanjing Bioheng Biotech Co., Ltd.
Collaborators
—
Condition
Systemic Lupus Erythematosus
Intervention
RD06-04 CART Cell Injection
Why stopped
R\&D strategy adjustment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-03